# A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People

> **NCT00508534** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 13 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** SB-751689

## Key facts

- **NCT ID:** NCT00508534
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2009-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508534, "A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00508534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*